Wenbo Dai, Guanyu Mu, Jiayi Ren, Sutao Hu, Rongxin Guo, Tian-shu Gu et al. Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome. // BMC Cardiovascular Disorders. – 2025. – DOI: 10.1186/s12872-025-04843-0. – URL: https://doi.org/10.1186/s12872-025-04843-0
Wenbo Dai, Guanyu Mu, Jiayi Ren, Sutao Hu, Rongxin Guo, Tian-shu Gu, Jingjin Che, Xianghong Ma, Tong Liu, Xue Wu, Jing-Kun Zhang, Gary Tse, Yajie Wang, Jian-Mei Zhou, Seung-Woon Rha, & Kangyin Chen (2025). Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-025-04843-0
Wenbo Dai, et al. “Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome.” BMC Cardiovascular Disorders, 2025. doi:10.1186/s12872-025-04843-0.
@article{Dai2025,
title = {Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome},
author = {Dai, Wenbo and Mu, Guanyu and Ren, Jiayi and Hu, Sutao and Guo, Rongxin and Gu, Tian-shu and Che, Jingjin and Ma, Xianghong and Liu, Tong and Wu, Xue and Zhang, Jing-Kun and Tse, Gary and Wang, Yajie and Zhou, Jian-Mei and Rha, Seung-Woon and Chen, Kangyin},
journal = {BMC Cardiovascular Disorders},
year = {2025},
doi = {10.1186/s12872-025-04843-0},
url = {https://doi.org/10.1186/s12872-025-04843-0}
}